12 August 2020 : Clinical Research
Effect of 2 Different Dosages of Rosuvastatin on Prognosis of Acute Myocardial Infarction Patients with New-Onset Atrial Fibrillation in Jinan, China
Jie Zhang12ABCDEFG, Ruiqi Feng3DEF, Misbahul Ferdous45DEF, Bo Dong5BCDG, Haitao Yuan5ABCDF, Peng Zhao5ABCDEFG*DOI: 10.12659/MSM.925666
Med Sci Monit 2020; 26:e925666
Table 1 Baseline characteristics of the two groups.
| Baseline clinical characteristics | 10 mg group (n=175) | 20 mg group (n=148) | P value |
|---|---|---|---|
| STEMI [No. (%)] | 121 (69.1) | 102 (68.9) | 0.965 |
| NSTEMI [No. (%)] | 54 (30.9) | 46 (31.1) | 0.965 |
| Gender (M/F) | 127/48 | 109/39 | 0.828 |
| Age, years | 63±9 | 62±11 | 0.676 |
| BMI (Kg/m) | 25.3±4.2 | 24.9±3.9 | 0.468 |
| Myocardial infarction [No. (%)] | 6 (3.4) | 7 (4.7) | 0.582 |
| PCI [No. (%)] | 8 (4.6) | 7 (4.7) | 0.999 |
| Previous stroke/TIA [No. (%)] | 7 (4.0) | 7 (4.7) | 0.789 |
| Previous vascular diseases [No. (%)] | 7 (4.0) | 5 (3.4) | 0.999 |
| Hypertension [No. (%)] | 70 (40.0) | 39 (26.4) | 0.010 |
| Diabetes mellitus [No.(%)] | 23 (13.1) | 29 (19.6) | 0.116 |
| Smoking [No. (%)] | 48 (27.4) | 46 (31.1) | 0.472 |
| Drinking[No. (%)] | 40 (22.9) | 41 (27.7) | 0.317 |
| β-blocker [No. (%)] | 115 (65.7) | 101 (68.2) | 0.630 |
| Calcium-channel blocker [No. (%)] | 39 (22.3) | 35 (23.6) | 0.772 |
| ACEI/ARB [No. (%)] | 112 (64.0) | 90 (60.8) | 0.555 |
| Diuretic [No. (%)] | 20 (11.4) | 16 (10.8) | 0.861 |
| PCI [No. (%)] | 152 (86.9) | 124 (83.8) | 0.435 |
| Thrombolysis [No. (%)] | 13 (7.4) | 12 (8.1) | 0.820 |
| Medication [No. (%)] | 10 (5.7) | 12 (8.1) | 0.395 |
| The variables were analyzed by t-test and χ test. | |||